WHO ICTRP trial
The direct effects of NSAIDS on osteoarthritic knee cartilage.
NL-OMON21305 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON21305 |
|---|---|
| Public title | The direct effects of NSAIDS on osteoarthritic knee cartilage. |
| Scientific title | Selective COX-2 inhibition is beneficial for matrix turnover: a clinical study. |
| Primary sponsor | UMC Utrecht Rheumatology & Clin. Immunology |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Osteoarthritis of the knee is a progressing degenerative joint disorder, characterised by joint pain and limitation of movement, leading to disability. Tissue changes comprise damage of joint cartilage, synovial inflammation and changes in… |
| Interventions | Celecoxib: 4 weeks, 2 times per day, 200 mg; Naproxen: 4 weeks, 3 times per day, 250 mg; Indomethacin: 4 weeks, 2 times per day, 50 mg. |
| Registration date | Aug 29, 2005 |
| Target size | 42 |
| Secondary IDs | NL126;NTR159; : N/A;ISRCTN90366351 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: